Expression of P-glycoprotein and multidrug resistance-associated protein on human brain-microvascular endothelial cells with electromagnetic stimulation

Colloids and Surfaces B: Biointerfaces

Volumn 91, Issue 1, 2012, Pages 57-62

  Kuo, Yung Chih ^a   Lu, Chin Hsun ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Azidothymidine; Electromagnetic field; Endothelium; Multidrug resistance associated protein; P glycoprotein; Saquinavir

Indexed keywords

ANTIRETROVIRAL DRUGS; AZIDOTHYMIDINE; DRUG RESISTANCE; EFFLUX PUMPS; EFFLUX TRANSPORTER; ELECTROMAGNETIC STIMULATION; ENDOTHELIUM; MEMBRANE PROPERTIES; P-GLYCOPROTEIN; PROBENECID; SAQUINAVIR; TRANSCYTOSIS; VERAPAMIL;

BLOOD VESSELS; BRAIN; ELECTROMAGNETIC FIELD EFFECTS; ELECTROMAGNETIC FIELDS; GLYCOPROTEINS; MONOLAYERS; PROTEINS;

ENDOTHELIAL CELLS;

CALCEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PROBENECID; SAQUINAVIR; VERAPAMIL; ZIDOVUDINE;

ARTICLE; ASTROCYTE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; ENDOCYTOSIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCYTOSIS;

BRAIN; ELECTROMAGNETIC FIELDS; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; HUMANS; P-GLYCOPROTEIN; P-GLYCOPROTEINS;

EID: 84855193227     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.10.035     Document Type: Article

References (29)

1. Eisenblatter T., Huwel S., Galla H.J. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res. 2003, 971:221-231.
2. Bauer B., Hartz A.M., Fricker G., Miller D.S. Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp. Biol. Med. 2005, 230:118-127.
3. Löscher W., Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 2005, 6:591-602.
4. Leslie E.M., Deeley R.G., Cole S.P. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 2005, 204:216-237.
5. Zong J., Pollack G.M. Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm. Res. 2000, 17:749-753.
6. Dallas S., Miller D.S., Bendayan R. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev. 2006, 58:140-161.
7. Sampath J., Adachi M., Hatse S., Naesens L., Balzarini J., Flatley R.M., Matherly L.H., Schuetz J.D. Role of MRP4 and MRP5 in biology and chemotherapy. AAPS PharmSci 2002, 4:1-9.
8. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15665-15670.
9. Haimeur A., Conseil G., Deeley R.G., Cole S.P. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology substrate specificity and regulation. Curr. Drug Metab. 2004, 5:21-53.
10. Allen J.D., Schinkel A.H. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol. Cancer Ther. 2002, 1:427-434.
11. Gupta A., Zhang Y., Unadkat J.D., Mao Q. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J. Pharmacol. Exp. Ther. 2004, 310:334-341.
12. Oscar K.J., Hawkins T.D. Microwave alteration of the blood-brain barrier system of rats. Brain Res. 1977, 126:281-293.
13. Albert E.N., Kerns J.M. Reversible microwave effects on the blood-brain barrier. Brain Res. 1981, 230:153-164.
14. Kuo Y.C., Kuo C.Y. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int. J. Pharm. 2008, 351:271-281.
15. Kuo Y.C., Yu H.W. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field. Colloids Surf. B 2011, 88:627-634.
16. Kuo Y.C., Lu C.H. Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins. Colloids Surf. B 2011, 87:139-145.
17. Kuo Y.C., Lu C.H. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. Colloids Surf. B 2011, 86:225-231.
18. Kuo Y.C., Lin C.W. Impact of arginine-modified solid lipid nanoparticles on the membrane charge of human brain-microvascular endothelial cells. Colloids Surf. B 2009, 72:201-207.
19. Zhang Y., Schuetz J.D., Elmquist W.F., Miller D.W. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 2004, 311:449-455.
20. Schinkel A.H., Wagenaar E., Mol C.A., Van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 1996, 97:2517-2524.
21. Leveque D., Jehl F. P-glycoprotein and pharmacokinetics. Anticancer Res. 1995, 15:331-336.
22. Robert J. Multidrug resistance in oncology: diagnostic and therapeutic approaches. Eur. J. Clin. Invest. 1999, 29:536-545.
23. Edwards J.E., Brouwder K.R., McNamara P.J. GF120918 a p-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats. Antimicrob. Agents Chemother. 2002, 46:2284-2286.
24. Bachmeier C.J., Spitzenberger T.J., Elmquist W.F., Miller D.W. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Pharm. Res. 2005, 22:1259-1268.
25. Zhang Y., Han H., Elmquist W.F., Miller D.W. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. 2000, 876:148-153.
26. Abla N., Chinn L.W., Nakamura T., Liu L., Huang C.C., Johns S.J., Kawamoto M., Stryke D., Taylor T.R., Ferrin T.E., Giacomini K.M., Kroetz D.L. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J. Pharmacol. Exp. Ther. 2008, 325:859-868.
27. Gimenez F., Fernandez C., Mabondzo A. Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins. J. Acquir. Immun. Defic. Syndr. 2004, 36:649-658.
28. Perloff M.D., Von Moltke L.L., Fahey J.M., Greenblatt D.J. Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells. J. Pharm. Pharmacol. 2007, 59:947-953.
29. Hirata M., Kusuzaki K., Takeshita H., Hashiguchi S., Hirasawa Y., Ashihara T. Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line. Anticancer Res. 2001, 21:317-320.